https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43747 Wed 28 Sep 2022 10:57:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52943 Wed 28 Feb 2024 16:14:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52050 1.1 million by 2058.2 The annual care costs are estimated to increase from $9.1 billion in 2017 to A$24.1 billion by 2056.3 Currently, there is a lack of a single valid and reliable data source for dementia identification. Welberry et al. recently demonstrated the feasibility of linking large population-based cohorts to administrative datasets to identify dementia cases at different stages of their trajectory.4 The Addressing Dementia Through Analysis of Population Traits and Risk Factors (ADAPTOR) project links data from a large Australian cohort study (followed up for 15 years) to various administrative health datasets. While the project links the same cohort study (the Sax Institute’s 45 And Up Study) and administrative datasets for dementia identification, it expands on Welberry et al.’s study by extending the data cut-off period from June 2014 to June 2018; including additional datasets and participants aged between 45–54 years; and stratifying data by sex and age group. The ADAPTOR project estimates dementia incidence, investigates the association between risk factors and incidence, and models the impact of modifiable risk factor reduction (e.g. increased physical activity, reduced alcohol consumption) on population-level dementia incidence. This paper presents preliminary findings from the project on sex and age-specific incidence of dementia and presents the most common data sources for dementia identification.]]> Wed 27 Sep 2023 15:29:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37320 Wed 24 Nov 2021 15:51:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30968 Wed 19 Jan 2022 15:15:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48815 Wed 14 Jun 2023 10:56:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33202 Wed 12 Sep 2018 15:47:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14000 Wed 11 Apr 2018 15:52:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13569 Wed 11 Apr 2018 15:29:46 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6972 Wed 11 Apr 2018 15:26:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11333 Wed 11 Apr 2018 15:18:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23413 Wed 11 Apr 2018 15:10:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15734 Wed 11 Apr 2018 15:04:13 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18895 0.2). Criteria for discriminant validity was not met, with only 10 of the 15 (67%) a-priori hypotheses supported. Test-retest reliability was acceptable for 40 of the 89 items (45%) and for three of the five domains. Significant floor effects were evident for all five domains. Conclusions: The SUNS demonstrates evidence for multiple features of validity and reliability as a measure of unmet needs for haematological cancer survivors. However, evidence supporting some psychometric properties was limited.]]> Wed 11 Apr 2018 14:52:48 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18915 2). This study aimed to validate this definition on larger data set. We hypothesized that patients defined by the 2 × AIS score > 2 cutoff have worse outcomes and use more resources than those without 2 × AIS score > 2 and that this would therefore be a better definition of polytrauma. METHODS: Patients injured between 2009 and 2011, with complete documentation of AIS by New South Wales Trauma Registry and 16 years and older were selected. Age and sex were obtained in addition to outcomes of ISS, hospital length of stay (LOS), intensive care unit (ICU) admission, ICU LOS, and mortality. We compared demographic characteristics and outcomes between patients with ISS greater than 15 who did and did not meet the 2 × AIS score > 2 definition. We then undertook regression analyses (logistic regression for binary outcomes [ICU admission and death] and linear regression for hospital and ICU LOS) to compare outcomes for patients with and without 2 × AIS score > 2, adjusting for sex and age categories. RESULTS: In the adjusted analyses, patients with 2 × AIS score > 2 had twice the odds of being admitted to the ICU compared with those without 2 × AIS score > 2 (odds ratio, 2.5; 95% confidence interval [CI], 2.2–2.8) and 1.7 times the odds of dying (95% CI, 1.4–2.0; p < 0.001 for both models). Patients with 2 × AIS score > 2 also had a mean difference of 1.5 days longer stay in the hospital compared with those without 2 × AIS score > 2 (95% CI, 1.4–1.7) and 1.6 days longer ICU stay (95% CI, 1.4–1.8; p < 0.001 for all models). CONCLUSION: Patients with 2 × AIS score > 2 had higher mortality, more frequent ICU admissions, and longer hospital and ICU stay than those without 2 × AIS score > 2 and represents a superior definition to the definitions for polytrauma currently in use..]]> Wed 11 Apr 2018 14:43:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21113 Wed 11 Apr 2018 13:31:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25988 Wed 11 Apr 2018 12:52:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7839 Wed 11 Apr 2018 12:28:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20351 Wed 11 Apr 2018 12:14:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13998 Wed 11 Apr 2018 11:35:10 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18743 Wed 11 Apr 2018 10:46:04 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12254 Wed 11 Apr 2018 10:40:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14003 Wed 11 Apr 2018 10:28:54 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25128 Wed 11 Apr 2018 10:21:32 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13568 Wed 11 Apr 2018 10:06:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13911 Wed 11 Apr 2018 10:01:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9728 Wed 11 Apr 2018 09:31:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21339 P<0.001), and fewer selected no change to their smoking (P<0.001). Numerous price-minimisation strategies (e.g. switching to cheaper brands/products) were endorsed, but remained constant across hypothetical scenarios; level of financial stress appeared to have little influence. Smokers indicating they would not change their smoking in response to price rises had higher levels of nicotine dependence. Discussion and Conclusions: Socially disadvantaged smokers endorsed numerous price-minimising strategies to maintain smoking at hypothetically increased costs. Larger cigarette price rises motivated more smokers to consider quitting, while price-resistant smokers appeared to have a more entrenched smoker status.]]> Wed 11 Apr 2018 09:29:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13928 Wed 11 Apr 2018 09:19:33 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27571 Wed 10 Nov 2021 15:12:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29399 Wed 10 Jul 2019 15:16:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27006 Wed 09 Mar 2022 16:01:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42925 Wed 07 Sep 2022 13:31:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34570 Wed 04 Sep 2019 09:48:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54542 Tue 27 Feb 2024 20:40:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20106 50μg/L or to that of arsenic exposure as quartiles or as duration. Arsenic concentration as quartiles and >50 μg/L did show a strong relationship with increased pulse pressure (adjusted OR: 3.54, 95% CI: 1.46–8.57), as did arsenic exposure for ≥10 years (adjusted OR: 5.25, 95% CI: 1.41–19.51). Arsenic as quartiles showed a dose response relationship with increased pulse pressure. Our study suggests an association between higher drinking water arsenic or duration and pulse pressure, but not hypertension.]]> Tue 24 Aug 2021 14:26:19 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48570 Tue 21 Mar 2023 18:40:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41945 Tue 16 Aug 2022 14:24:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43867 Tue 04 Oct 2022 12:28:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35752 Thu 28 Nov 2019 12:40:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51873 Thu 21 Sep 2023 10:23:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44675 Thu 20 Oct 2022 08:35:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38606 2 or a chronic health condition recruited from general practices was conducted. The arms included (1) BBL-GP, a web-based intervention augmented with an in-person diet and physical activity consultation; (2) a single clinician-led group, Lifestyle Modification Program (LMP); and (3) a web-based control. The primary outcome was the Australian National University Alzheimer Disease Risk Index Short Form (ANU-ADRI-SF). Results: Baseline assessments were conducted on 128 participants. A total of 125 participants were randomized to 3 groups (BBL-GP=42, LMP=41, and control=42). At immediate, week 18, week 36, and week 62 follow-ups, the completion rates were 43% (18/42), 57% (24/42), 48% (20/42), and 48% (20/42), respectively, for the BBL-GP group; 71% (29/41), 68% (28/41), 68% (28/41), and 51% (21/41), respectively, for the LMP group; and 62% (26/42), 69% (29/42), 60% (25/42), and 60% (25/42), respectively, for the control group. The primary outcome of the ANU-ADRI-SF score was lower for the BBL-GP group than the control group at all follow-ups. These comparisons were all significant at the 5% level for estimates adjusted for baseline differences (immediate: difference in means -3.86, 95% CI -6.81 to -0.90, P=.01; week 18: difference in means -4.05, 95% CI -6.81 to -1.28, P<.001; week 36: difference in means -4.99, 95% CI -8.04 to -1.94, P<.001; and week 62: difference in means -4.62, 95% CI -7.62 to -1.62, P<.001). Conclusions: A web-based multidomain dementia risk reduction program augmented with allied health consultations administered within the general practice context can reduce dementia risk exposure for at least 15 months. This study was limited by a small sample size, and replication on a larger sample with longer follow-up will strengthen the results.]]> Thu 18 Nov 2021 09:43:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42106 Thu 18 Aug 2022 13:32:29 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25771 Thu 13 Aug 2020 08:45:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23946 Thu 13 Aug 2020 08:44:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27012 Thu 04 Nov 2021 10:39:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34659 20%), but this was only statistically significant in adjusted analyses (unadjusted hazard ratio [HR], 0.79; 95% confidence interval [CI] , 0.58-1.07; P=0.13; adjusted HR, 0.77; 95% CI, 0.59-0.99; P=0.045). Older age (75-84 years; HR, 4.9; 95% CI, 2.8-8.7; P < 0.001) and increasing stroke severity (HR, 1.5; 95% CI, 1.3-1.9; P < 0.001) were associated with increased mortality, while being married (HR, 0.70; 95% CI, 0.49-0.99; P=0.042) was associated with increased likelihood of survival. Cardiovascular disease (including stroke) was listed either as the primary or secondary cause of death in 80% (211/264) of all deaths. Conclusions: Our results demonstrate the potential long-term and sustained benefit of nurse-initiated multidisciplinary protocols for management of fever, hyperglycemia, and swallowing dysfunction. These protocols should be a routine part of acute stroke care.]]> Thu 03 Feb 2022 12:20:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7332 Sat 24 Mar 2018 10:45:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7893 Sat 24 Mar 2018 10:44:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9278 Sat 24 Mar 2018 10:44:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7393 Sat 24 Mar 2018 08:42:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7195 Sat 24 Mar 2018 08:42:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7753 Sat 24 Mar 2018 08:41:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7230 Sat 24 Mar 2018 08:40:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7789 Sat 24 Mar 2018 08:39:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7041 Sat 24 Mar 2018 08:37:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9648 60 years is growing faster than any other age group and is expected to reach 2 billion worldwide by 2050. Internationally and nationally, considerable efforts are being made to promote active ageing. However, Australia lacks the kind of comprehensive longitudinal research underway in Europe and North America. Although Australia does have a number of longitudinal studies designed to address various issues of health and ageing among older adults, only a few of these studies include a broad and comprehensive range of physical and biological measures. The Hunter Community Study (HCS) is a collaborative study between the University of Newcastle’s School of Medicine and Public Health and the Hunter New England Area Health Service. It is a multi disciplinary initiative that was established to fill some existing gaps in ageing research in Australia and is unique in that it has collected detailed information across all six key policy themes as identified in the Framework for an Australian Ageing Research Agenda.]]> Sat 24 Mar 2018 08:35:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7239 Sat 24 Mar 2018 08:33:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1329 Sat 24 Mar 2018 08:32:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1064 Sat 24 Mar 2018 08:32:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1244 Sat 24 Mar 2018 08:28:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1709 Sat 24 Mar 2018 08:27:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15698 Sat 24 Mar 2018 08:22:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13994 Sat 24 Mar 2018 08:20:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:10664 Sat 24 Mar 2018 08:12:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12325 Sat 24 Mar 2018 08:11:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12277 Sat 24 Mar 2018 08:10:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:10458 Sat 24 Mar 2018 08:09:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11179 Sat 24 Mar 2018 08:08:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18226 Sat 24 Mar 2018 08:04:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18125 Sat 24 Mar 2018 08:04:47 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18124 Sat 24 Mar 2018 08:04:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18170 Sat 24 Mar 2018 08:04:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18127 Sat 24 Mar 2018 08:04:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18126 Sat 24 Mar 2018 08:04:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18128 Sat 24 Mar 2018 08:04:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20480 Sat 24 Mar 2018 07:59:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19114 Sat 24 Mar 2018 07:55:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5594 Sat 24 Mar 2018 07:49:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5783 Sat 24 Mar 2018 07:44:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5242 Sat 24 Mar 2018 07:44:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29170 Sat 24 Mar 2018 07:35:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27416 Sat 24 Mar 2018 07:35:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29325 Sat 24 Mar 2018 07:34:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28121 Sat 24 Mar 2018 07:24:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28777 11 mmol/l), and swallowing dysfunction in intervention stroke units. Results: Data from 1804 patients (718 preintervention; 1086 postintervention) showed that significantly more patients admitted to hospitals allocated to the intervention group received care according to the fever (n = 186 of 603, 31% vs. n = 74 of 483, 15%, P < 0·001), hyperglycemia (n = 22 of 603, 3·7% vs. n = 3 of 483, 0·6%, P = 0·01), and swallowing dysfunction protocols (n = 241 of 603, 40% vs. n = 19 of 483, 4·0%, P ≤ 0·001). Significantly more patients in these intervention stroke units received four-hourly temperature monitoring (n = 222 of 603, 37% vs. n = 90 of 483, 19%, P < 0·001) and six-hourly glucose monitoring (194 of 603, 32% vs. 46 of 483, 9·5%, P < 0·001) within 72 hours of admission to a stroke unit, and a swallowing screen (242 of 522, 46% vs. 24 of 350, 6·8%, P ≤ 0·0001) within the first 24 hours of admission to hospital. There was no difference between the groups in the treatment of patients with fever with paracetamol (22 of 105, 21% vs. 38 of 131, 29%, P = 0·78) or their hyperglycemia with insulin (40 of 100, 40% vs. 17 of 57, 30%, P = 0·49). Interpretation Our intervention resulted in better protocol adherence in intervention stroke units, which explains our main trial findings of improved patient 90-day outcomes. Although monitoring practices significantly improved, there was no difference between the groups in the treatment of fever and hyperglycemia following acute stroke. A significant link between improved treatment practices and improved outcomes would have explained further the success of our intervention, and we are still unable to explain definitively the large improvements in death and dependency found in the main trial results. One potential explanation is that improved monitoring may have led to better overall surveillance of deteriorating patients and faster initiation of treatments not measured as part of the main trial.]]> Sat 24 Mar 2018 07:23:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4616 Sat 24 Mar 2018 07:21:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37590 Mon 29 Mar 2021 10:17:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44903 Mon 24 Oct 2022 16:10:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32822 Mon 23 Sep 2019 13:44:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32848 Mon 23 Sep 2019 12:46:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20617 Mon 23 Sep 2019 11:49:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27929 Mon 20 Mar 2023 12:45:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34326 Fri 25 Sep 2020 10:20:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27874 Fri 23 Oct 2020 11:58:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46576 n = 10,892, 52.8% women). We calculated country-specific prevalence of low grip strength, slow GS (≤ 0.8 m/s), and both measures combined. Using multivariable negative binomial regression, we separately assessed associations between low grip strength, slow GS, and both measures combined, with the WHO Disability Assessment Schedule 2.0, accounting for selected socioeconomic factors. In women, low grip strength ranged from 7 in South Africa to 51% in India; in men, it ranged from 17 in Russia to 51% in Mexico. Country-specific proportions of slow GS ranged from 77 in Russia, to 33% in China. The concomitant presence of both was the lowest in South Africa and the highest in India (12.3% vs. 33%). Independent of age, those with both low grip strength and slow GS had between 1.2- and 1.5-fold worse functional disability scores, independent of comorbidities, low education, and low wealth (all country-dependent). Low grip strength, slow GS, and the combination of both, were all associated with higher levels of functional disability, thus indicating these objective measures offer a reasonably robust estimate for potential poor health outcomes.]]> Fri 23 Jun 2023 12:19:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38012 Fri 23 Jul 2021 15:12:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20122 Fri 10 Mar 2023 19:27:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47867 Fri 03 Feb 2023 14:14:59 AEDT ]]>